Episode
Harnessing The Power of Profit: The Business Case for Women’s Health Startups with Erin Lambroza
- Podcast
- Innovate and Elevate
- Published
- Jun 18, 2024
- Duration seconds
- 976
- Processing state
not_requested- Canonical source
- https://www.innovateandelevatepodcast.com/episodes/erin-lambroza-the-power-of-profit
Actions
POST https://stenobird.com/v1/public/podcasts/innovate-and-elevate-6703724/episodes/harnessing-the-power-of-profit-the-business-case-for-women-s-health-startups-with-erin-lambroza/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/innovate-and-elevate-6703724/harnessing-the-power-of-profit-the-business-case-for-women-s-health-startups-with-erin-lambroza.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode, Sharon is joined by Erin Lambroza, Vice President of L Catterton, a consumer-focused private equity firm. Erin holds Director roles on the boards of Alice Mushrooms—a functional health supplement business pairing chocolate with the power of adaptogens from legal mushrooms; an unannounced beauty and wellness platform providing solutions to women who are navigating menopause; and Yummers, a pet food company founded by “Queer Eye” stars Jonathan Van Ness and Antoni Porowski alongside the former CMO of Petco. In this conversation, Erin and Sharon discuss what makes a women's health company fundable and how to navigate the challenges in this space. Erin brings her extensive experience in early-stage investments with a focus on health and wellness to provide invaluable advice for founders and investors alike. Erin emphasizes that the success of a women’s health startup relies on the same factors as any other sector: a growing market, scalable growth, and demonstrated product-market fit. She highlights the importance of understanding unit economics, ensuring that the business model is sustainable and profitable, especially after the first year in the market. The conversation also touches on the historical challenges in women’s health, such as underinvestment and the lack of viable exit paths, which make fundraising particularly difficult. Erin notes that overcoming these obstacles requires innovation at the research level to build a foundation for profitable businesses. The episode delves into the historical context of women's health, revealing that women were excluded from clinical trials until 1993, resulting in a significant lack of comprehensive data and chronic underrepresentation in healthcare research. Erin also discusses the origins of the word "hyste…